Recognition TLR7 Signaling Beyond Endosomal Dendritic Cells

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition

This information is current as of September 29, 2021.
Jennifer P. Wang, Ping Liu, Eicke Latz, Douglas T. Golenbock, Robert W. Finberg and Daniel H. Libraty

J Immunol 2006; 177:7114-7121; ; doi: 10.4049/jimmunol.177.10.7114

http://www.jimmunol.org/content/177/10/7114

References This article cites 38 articles, 21 of which you can access for free at:

http://www.jimmunol.org/content/177/10/7114.full#ref-list-1

Why The JI? Submit online.
Rapid Reviews! 30 days* from submission to initial decision

No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication

*average

Subscription Information about subscribing to The Journal of Immunology is online at:

http://jimmunol.org/subscription

Permissions Submit copyright permission requests at:

http://www.aai.org/About/Publications/JI/copyright.html

Email Alerts Receive free email-alerts when new articles cite this article. Sign up at:

http://jimmunol.org/alerts

The Journal of Immunology is published twice each month by

The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.

The Journal of Immunology

Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition1

Jennifer P. Wang,2* Ping Liu,Eicke Latz,* Douglas T. Golenbock,* Robert W. Finberg,* and Daniel H. Libraty

TLR7 senses RNA in endosomal compartments. TLR7 expression and signaling have been demonstrated in plasmacytoid and myeloid dendritic cells, B cells, and T cells. The regulation of TLR7 signaling can play a crucial role in shaping the immune response to RNA viruses with different cellular tropisms, and in developing adjuvants capable of promoting balanced humoral and cell-mediated immunity. We used unique characteristics of two ssRNA viruses, dengue virus and influenza virus, to delineate factors that regulate viral RNA-human TLR7 signaling beyond recognition in endosomal compartments. Our data show that TLR7 recognition of enveloped RNA virus genomes is linked to virus fusion or uncoating from the endosome. The signaling threshold required to activate TLR7-type I IFN production is greater than that required to activate TLR7-NF-B-IL-8 produc- tion. The higher order structure of viral RNA appears to be an important determinant of TLR7-signaling potency. A greater understanding of viral RNA-TLR7 activity relationships will promote rational approaches to interventional and vaccine strategies for important human viral pathogens. The Journal of Immunology, 2006, 177: 7114–7121.

nduction of the type I IFN pathway is a critical aspect of innate immunity to many viral infections. Nearly all cell types can produce some type I IFN in response to viruses,
Human pDCs express high levels of TLR7, whereas human mDCs express intermediate levels of both TLR7 and TLR8 (2, 9). TLR7 expression and signaling function have also been demonstrated in naive B cells (10), and naive and effector memory CD4ϩ T cells (11). This makes TLR7 activation potentially important in shaping the immune responses to RNA viruses with different cellular tropisms. It also raises interest in potent TLR7 agonists as vaccine adjuvants capable of directly targeting all cells involved in generating effective humoral and cell-mediated immunity. TLR7 recognizes and is activated by RNA, either uridine-containing ssRNA (12, 13) or synthetic guanosine-like compounds, such as resiquimod (R-848) (14, 15). Spatial recognition of RNA within endosomes is a key regulator of TLR7 activation. Acidifi- cation of endosomal compartments is required for RNA virusTLR7 signaling (16). Beyond spatial recognition, little is known about other factors regulating TLR7 signaling and determinants of TLR7 agonist potency. Differences in TLR7-signaling capacity have been reported between ssRNA and monomeric ligands (17), sequences within synthetic RNAs (12, 18), and among different sources of cellular RNA (13). The natural ligands for TLR7 activation, and particularly TLR7-type I IFN signaling, are ssRNA viruses that gain access to TLR7-containing endocytic organelles (4, 16, 17, 19). Unique aspects of ssRNA viruses can be used as tools to elucidate regulation of TLR7 signaling beyond spatial recognition.

I

and several mechanisms of viral recognition leading to type I IFN production have been identified (1). The amount, kinetics, and regulation of type I IFN in dendritic cells (DCs)3 play a central role in shaping antiviral innate immune responses. In particular, plasmacytoid DCs (pDCs) are highly specialized cells that produce large amounts of IFN-␣ in response to a wide range of enveloped viruses and other microbial stimuli (2, 3). They likely play an important role in controlling systemic infections with enveloped viruses such as HIV-1, dengue, and HSV (4–6). Through IFN-␣ secretion and other effects, pDCs interact with surrounding myeloid DCs (mDCs) to induce innate antiviral immunity and shape effective adaptive antiviral responses (2, 7). pDCs and mDCs have several potential mechanisms to recognize viruses and trigger activation (1, 8). For RNA viruses, TLRs 7 and 8 are important mediators of recognition and innate immune activation. TLRs 7 and 8 are members of the TLR9 subfamily that sense pathogen-derived RNA (TLR 7/8) and DNA (TLR9) moieties intracellularly, and signal through the adaptor MyD88 (9).

*Department of Medicine and Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, MA 01655

Received for publication February 8, 2006. Accepted for publication August 25, 2006.

We examined viral RNA (vRNA)-TLR7 recognition and signaling using two ssRNA viruses, dengue-2 virus (D2V) and influenza A X31 virus (flu X31). D2V is an enveloped flavivirus containing a single 11 kb, positive-strand, ssRNA genome. The vRNA has a capped 5Ј-triphosphate end. Virus fusion and uncoating from endocytic vacuoles is pH dependent and occurs in early endosomes through a type II fusion process (20, 21). Influenza A viruses are enveloped orthomyxoviruses containing a segmented, negativestrand, ssRNA genome totaling 13.5 kb. The vRNA segments have uncapped, 5Ј-triphosphate ends. Virus fusion and uncoating from endocytic vacuoles is pH dependent and occurs in late endosomes through a type I fusion process (21, 22). Flu X31 is a reassortment

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the National Institutes of Health (NIH U19 AI57319, R21 AI060791, and K08AI053542). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

2 Address correspondence and reprint requests to Dr. Jennifer P. Wang, Department of Medicine, University of Massachusetts Medical School, LRB 219, 55 Lake Avenue North, Worcester, MA 01655. E-mail address: [email protected]

3 Abbreviations used in this paper: DC, dendritic cell; pDC, plasmacytoid DC; mDC, myeloid DC; vRNA, viral RNA; D2V, dengue-2 virus; siRNA, short-interfering RNA; ODN, oligodeoxyribonucleotide; MOI, multiplicity of infection; ER, endoplasmic reticulum; SNV, Sin Nombre virus.

  • Copyright © 2006 by The American Association of Immunologists, Inc.
  • 0022-1767/06/$02.00

  • The Journal of Immunology
  • 7115

of A/PR/8/34 (H1N1) (PR8) virus with A/Aichi/68 (H3N2). By using these RNA viruses, synthetic ssRNAs, and R-848 to stimulate pDCs and a TLR7-transfected cell line, we were able to delineate key elements affecting TLR7 activation. TLR7 recognition of enveloped ssRNA virus genomes appeared linked to the virus fusion or uncoating process from endosomal compartments. The signaling threshold required to activate TLR7-type I IFN production was greater than that required to activate TLR7-NF-␬B-IL-8 production, but the specialized nature of pDCs allowed them to produce IFN-␣ in response to low potency TLR7 agonists. Finally, the higher order structure of viral genomic RNAs was an important determinant of TLR7-signaling potency.

resulted in a Ͼ104 PFU/ml decrease in the titers of both viruses, as confirmed by limiting dilution plaque assays. Stably transfected HEK/hTLR7/ NF-␬B cells and HEK/NF-␬B control cells were continuously passaged and maintained in DMEM (Invitrogen Life Technologies) supplemented with 10% FCS.

RNA isolation and transfection

Viral genomic RNAs from influenza virus and D2V were isolated from virus stocks using the QIAamp Viral RNA kit (Qiagen). Sin Nombre virus (SNV) G2 RNA was obtained by T7 polymerase-driven in vitro transcription of a pcDNA 3.1/SNV G2 plasmid (a gift from C. Schmaljohn, U.S. Army Medical Research Institute for Infectious Diseases, Fort Detrick, MD) using the Riboprobe In Vitro Transcription kit (Promega) followed by RNA extraction and isolation using phenol/chloroform and isopropanol. Isolated vRNAs were treated with RNase-free DNase I for 30 min at 37°C. DNase was removed by phenol/chloroform extraction and isopropanol precipitation of the RNA. In some experiments, influenza vRNA was then treated with proteinase K (Promega) or Triton X-100 (Sigma-Aldrich), and the vRNA was re-extracted as noted above. Or, the 5Ј-␤ and -␥ phosphates were removed from influenza vRNA using tobacco acid pyrophosphatase (Epicentre Biotechnologies) according to the manufacturer’s instructions. 5Ј-Monophosphorylated SNV G2 RNA, obtained after sequential shrimp alkaline phosphatase (Epicentre Biotechnologies) and T4 polynucleotide kinase (New England Biolabs) treatments, was used as a negative control substrate for tobacco acid pyrophosphatase treatment. The vRNA nucleotide concentrations were measured by absorbance at 260 ␭ (A260), and the amount of vRNA segments in a preparation was calculated as follows: vRNA segments (pM) ϭ (amount of vRNA nucleotides (g)/virion m.w.) ϫ number of RNA segments/virion ϫ 1 ϫ 10Ϫ12. In some experiments, influenza and dengue-2 vRNAs were UV-cross-linked before transfection, using the same procedure as described previously. The electrophoretic mobility of untreated and UV-irradiated vRNA was examined on 0.6% agarose gels containing 1 M urea. Purified vRNA was loaded with urea sample buffer (6 M final concentration) and heated at 70°C ϫ 10 min. RNA bands were detected by SYBR Green II RNA gel stain (Invitrogen Life Technologies). HEK/hTLR7/NF-␬B cells, HEK/NF-␬B control cells, and human pDCs were transfected with the DNA-free vRNA preparations and synthetic RNAs using Lipofectamine 2000 (Invitrogen Life Technologies). Cells were seeded in flat-bottom 96-well plates at a density of 5 ϫ 104 cells/well. Cells were washed, and the medium was replaced with serum-free OptiMEM (Invitrogen Life Technologies). RNA preparations at the indicated concentrations were complexed with 0.5 ␮l of Lipofectamine/well for 20–30 min at room temperature. The RNA-Lipofectamine complexes were then added to the cells at a final volume of 250 ␮l/well, and incubated at 37°C, 5% CO2 for 40 h. Cell culture supernatants were collected, aliquoted, and stored at Ϫ20°C for ELISA. For HEK/hTLR7/NF-␬B and HEK/ NF-␬B cells, luciferase activity was measured from cell lysates using the Dual-Glo Luciferase Assay System (Promega).

Materials and Methods

Viruses, reagents, and cells

Influenza A virus X31 strain was purchased from Charles River International and titered by limiting dilution plaque assay on Madin-Darby canine kidney cells in the presence of trypsin (0.2 ␮g/ml). D2V strains 16681 or New Guinea C were used in all experiments, and no experimental differences were observed between the two strains. The D2V strains were propagated in the mosquito cell line C636 and virus stocks were titered by limiting dilution plaque assay on Vero cells. Virus stocks were free of Mycoplasma contamination, as determined by PCR (American Type Culture Collection). There was also no endotoxin contamination, as determined by Limulus amebocyte lysate assay (BioWhittaker) or ability to activate a TLR4-transfected HEK293 cell line. R-848 was a gift from 3M Pharmaceuticals, and CpG 2336 was purchased from Coley Pharmaceuticals. ssRNA40 (12) was purchased from InvivoGen, short-interfering RNA (siRNA) 9.2 (18) from Dharmacon, and polyuridylic acid (poly(U)) from Sigma-Aldrich. IRS 661 and control sequences (23) were synthesized on a phosphorothioate backbone by MWG Biotech. Sequences for influenza vRNA segments 5Ј conserved end (16 nt), 3Ј conserved end (14 nt), and a 49 nt panhandle structure have been previously published (24). These sequences were synthesized with a 5Ј-monophosphate by Dharmacon. All fluorophore-conjugated mAbs were purchased from BD Biosciences/BD Pharmingen. Human pDCs were isolated from the blood of adult, healthy donors under a protocol approved by the University of Massachusetts Medical School Institutional Review Board. PBMC were isolated using FicollHypaque density centrifugation, and pDCs were positively selected from the PBMC using BDCA-4 magnetic beads according to the manufacturer’s instructions (Miltenyi Biotec). Human pDC purity was Ն85% as assessed by FACS staining (lineageϪCD123ϩHLA-DRϩ). HEK293 cells stably transfected with human (h) TLR7 and a NF-␬B luciferase construct (HEK/ hTLR7/NF-␬B), and the parent HEK293 cells stably transfected with a NF-␬B luciferase construct (HEK/NF-␬B) were a gift from the Eisai Research Institute (M. Lamphier, Andover, MA). Mouse pDCs were isolated from pooled bone marrow cells cultured in a 37°C, 5% CO2 incubator for 7 days in the presence of 10 ng/ml mouse recombinant fms-related tyrosine kinase 3 ligand (Flt3L) (R&D Systems). Flt3L-stimulated bone marrow cells were sorted on a FACSAria (BD Biosciences) to isolate the pDCs (CD11bϪCD45Rhigh). Mouse pDC purity was Ն98%. TLR7Ϫ/Ϫ and TLR9Ϫ/Ϫ mice were backcrossed to C57/BL6J mice for more than six generations (gift from S. Akira, Osaka University, Osaka, Japan). Age-matched, wild-type, control C57/BL6J mice were purchased from Jackson ImmunoResearch Laboratories. All mice were bred and housed in the Animal Facility at the University of Massachusetts Medical School.

ELISA

Cytokine levels in cell culture supernatants were measured using commercially available ELISA kits following the manufacturer’s instructions: hIFN-␣ (Bender MedSystems module set), hIFN-␤ (BioSource International), hIL-8 (R&D Systems Duoset). Samples were assayed in duplicate, and at dilutions that fell within the range of the standard curves.

Electron microscopy

D2V was adsorbed to isolated human pDCs at 4°C for 1 h while rocking (multiplicity of infection (MOI) ϭ 10) to allow synchronous virus binding without entry. The cells were then incubated at 37°C ϫ 5 min, fixed with fresh 2.5% glutaraldehyde ϫ 20 min, washed two times, and placed again in 2.5% glutaraldehyde overnight at 4°C. The cells were postfixed in 1% osmium tetroxide, and processed using standard techniques (25). The cell block was ultrathin sectioned (70-nm thick) on a Reichert-Jung Ultra-cut E with a diamond knife. Sections were collected on copper support grids, exposed to lead citrate and uranyl acetate contrast, and examined with a Philips CM 10 transmission electron microscope at 80 kV.

Cell culture

Isolated human pDCs were cultured in RPMI 1640 medium (Invitrogen Life Technologies) supplemented with 10% FCS (HyClone), and 10 ng/ml rIL-3 (R&D Systems). A total of 5 ϫ 104 human pDCs and stimuli at the indicated concentrations were placed in 96-well flat-bottom plates with a final volume of 200 ␮l/well. After 20 h in a 37°C/5% CO2 incubator, the plates were centrifuged at 300 ϫ g for 5 min, and cell-free supernatants were collected, aliquoted, and stored at Ϫ20°C for ELISA. Cell viability was assessed by trypan blue exclusion. In some experiments, human pDCs were preincubated with IRS 661, control oligodeoxyribonucleotide (ODN) sequence, bafilomycin A1 (Calbiochem), or chloroquine (Sigma-Aldrich) at the indicated concentrations for 30 min before addition of the stimuli. In some experiments, influenza virus and D2V were heat inactivated at 56°C for 30 min, or UV inactivated with 2300 ␮W/cm2 of 254 nm UVA light for 15 min on ice, before addition to the pDCs. Heat and UV inactivation

Measurement of intraendosomal pH

Intraendosomal pH in human pDCs exposed to chloroquine or bafilomycin A1 was determined using a modification of previously described methods (26). Briefly, pDCs were seeded in a flat-bottom 96-well plate and incubated for 3 h with 10 kDa dextran-Oregon Green 488 (1 mg/ml) (Molecular Probes/Invitrogen Life Technologies). After washing, trypan blue was

  • 7116
  • vRNA AND TLR7 SIGNALING

FIGURE 1. D2V enters endocytic vacuoles in human pDCs. D2V (MOI ϭ 10) was adsorbed to purified human pDCs ϫ 1 h at 4°C, warmed to 37°C ϫ 5 min, and then fixed with glutaraldehyde. a, Enveloped D2V particles (arrows) in cytoplasm or small endocytic vesicles, and in larger endocytic vacuoles. b, D2V particles (arrows) in close association with Golgi apparatus and smooth ER (arrowheads). c, D2V particles (arrow) entering a large endocytic vacuole with Golgi/smooth ER membrane characteristics (arrowhead). Original magnification, ϫ21,000 (a and b) and ϫ52,000 (c).

added for 3 min to quench the fluorescence of any remaining extracellular or surface bound dextran-Oregon Green 488. Cells were washed, and the ratio of fluorescence emissions at 520 nm from excitation at 490 and 450 nm (Ex490/Ex450) was determined on a Gemini EM microplate spectrofluorometer (Molecular Devices). The average intraendosomal pH was calculated using a pH standard curve generated in nigericin permeabilized pDCs with high-potassium calibration buffers between pH 4.0 and 6.5.

contamination as contributing to the IFN-␣ secretion. By electron microscopy, we observed intracellular enveloped D2V particles in the cytoplasm and large endocytic vacuoles of human pDCs 5 min after virus entry (Fig. 1a). The enveloped D2V particles were closely associated with the Golgi apparatus and smooth endoplasmic reticulum (ER) (Fig. 1b). Virus particles appeared to traffic from the cytoplasmic space or small enveloped vesicles to larger endocytic vacuoles that had membrane characteristics of Golgi or smooth ER (Fig. 1c). D2V entered endocytic compartments in human pDCs, the presumed location of TLR7-vRNA interactions (16, 17). Next, we stimulated human pDCs with D2V, influenza virus, R-848 (TLR7 agonist), and CpG 2336 (TLR9 agonist) in the presence and absence of a TLR7 antagonist, IRS 661. The TLR7 antagonistic properties of IRS 661 and a control ODN as reported by Barrat et al. (23) were confirmed in our laboratory using purified mouse TLR7Ϫ/Ϫ and TLR9Ϫ/Ϫ pDCs. In human pDCs, D2V, influenza virus, and R-848-induced IFN-␣ production was significantly lower in the presence of IRS 661 compared with no inhibitor or the control ODN (Fig. 2). Like influenza virus (23), dengue virus activated human pDCs by a TLR7-dependent mechanism.

Statistical analysis

The SPSS software package (version 12.0) was used for statistical analyses. For normally distributed variables, comparisons between two groups were analyzed using the paired or unpaired Student t test, as appropriate. For nonnormally distributed variables, comparisons between two paired groups were analyzed using the nonparametric Wilcoxon ranked-sign test. A p value Ͻ0.05 was considered significant.

Results

D2V is taken up by human pDCs and stimulates IFN-production in a TLR7-dependent manner

D2V was able to induce IFN-␣ secretion from human pDCs. IFN-␣ production was abolished by heat inactivation at 56°C (Ref. 5 and data not shown). These results showed that D2V envelope protein binding to the cell surface is necessary for pDC IFN-␣ secretion (27), and excluded endotoxin or DNA

FIGURE 2. D2V activates human pDCs in a TLR7-

dependent manner. Purified human pDCs were stimulated with live D2V (MOI ϭ 2.5), live influenza virus (Flu X31, MOI ϭ 0.25), R-848 (1 ␮M), and CpG 2336 (0.6 ␮M) alone (f), in the presence of a control ODN (2.8 ␮M) (Ⅺ), or in the presence of the TLR7 inhibitor, IRS 661 (2.8 ␮M) (p). Cell culture supernatants were collected after 20 h and IFN-␣ levels were measured by ELISA. Values are the percentage of IFN-␣ production compared with the stimulus alone (mean Ϯ SEM, n ϭ 4 independent experiments). The mean absolute levels of IFN-␣ by the stimuli alone were 948 pg/ml (D2V), 29,490 pg/ml (Flu X31), 18,381 pg/ml (R-848), and 53,864 (CpG 2336). ءence of IRS 661 compared with IRS control ODN.

Recommended publications
  • Taxonomy of the Order Bunyavirales: Update 2019

    Taxonomy of the Order Bunyavirales: Update 2019

    Archives of Virology (2019) 164:1949–1965 https://doi.org/10.1007/s00705-019-04253-6 VIROLOGY DIVISION NEWS Taxonomy of the order Bunyavirales: update 2019 Abulikemu Abudurexiti1 · Scott Adkins2 · Daniela Alioto3 · Sergey V. Alkhovsky4 · Tatjana Avšič‑Županc5 · Matthew J. Ballinger6 · Dennis A. Bente7 · Martin Beer8 · Éric Bergeron9 · Carol D. Blair10 · Thomas Briese11 · Michael J. Buchmeier12 · Felicity J. Burt13 · Charles H. Calisher10 · Chénchén Cháng14 · Rémi N. Charrel15 · Il Ryong Choi16 · J. Christopher S. Clegg17 · Juan Carlos de la Torre18 · Xavier de Lamballerie15 · Fēi Dèng19 · Francesco Di Serio20 · Michele Digiaro21 · Michael A. Drebot22 · Xiaˇoméi Duàn14 · Hideki Ebihara23 · Toufc Elbeaino21 · Koray Ergünay24 · Charles F. Fulhorst7 · Aura R. Garrison25 · George Fú Gāo26 · Jean‑Paul J. Gonzalez27 · Martin H. Groschup28 · Stephan Günther29 · Anne‑Lise Haenni30 · Roy A. Hall31 · Jussi Hepojoki32,33 · Roger Hewson34 · Zhìhóng Hú19 · Holly R. Hughes35 · Miranda Gilda Jonson36 · Sandra Junglen37,38 · Boris Klempa39 · Jonas Klingström40 · Chūn Kòu14 · Lies Laenen41,42 · Amy J. Lambert35 · Stanley A. Langevin43 · Dan Liu44 · Igor S. Lukashevich45 · Tāo Luò1 · Chuánwèi Lüˇ 19 · Piet Maes41 · William Marciel de Souza46 · Marco Marklewitz37,38 · Giovanni P. Martelli47 · Keita Matsuno48,49 · Nicole Mielke‑Ehret50 · Maria Minutolo3 · Ali Mirazimi51 · Abulimiti Moming14 · Hans‑Peter Mühlbach50 · Rayapati Naidu52 · Beatriz Navarro20 · Márcio Roberto Teixeira Nunes53 · Gustavo Palacios25 · Anna Papa54 · Alex Pauvolid‑Corrêa55 · Janusz T. Pawęska56,57 · Jié Qiáo19 · Sheli R. Radoshitzky25 · Renato O. Resende58 · Víctor Romanowski59 · Amadou Alpha Sall60 · Maria S. Salvato61 · Takahide Sasaya62 · Shū Shěn19 · Xiǎohóng Shí63 · Yukio Shirako64 · Peter Simmonds65 · Manuela Sironi66 · Jin‑Won Song67 · Jessica R. Spengler9 · Mark D. Stenglein68 · Zhèngyuán Sū19 · Sùróng Sūn14 · Shuāng Táng19 · Massimo Turina69 · Bó Wáng19 · Chéng Wáng1 · Huálín Wáng19 · Jūn Wáng19 · Tàiyún Wèi70 · Anna E.
  • Interaction with Other Flaviviruses (Pre-Existing Immunity, Co-Infection, Cross- Reactivity)

    Interaction with Other Flaviviruses (Pre-Existing Immunity, Co-Infection, Cross- Reactivity)

    Interaction with other flaviviruses (pre-existing immunity, co-infection, cross- reactivity) Alan D.T. Barrett Department of Pathology Sealy Center for Vaccine Development University of Texas Medical Branch Galveston TX Flavivirus genome 50nm particle. SS, +RNA genome. 10 genes, 3 structural. Beck, A. Barrett, ADT. (2015) Exp Rev Vaccines. 1-14. 2 Flavivirus E protein epitopes • Studies with human and mouse polyclonal sera show extensive serologic cross-reactivities between flaviviruses in terms of physical (ELISA) and biological (HAI and neutralization) assays • Studies with mouse, non-human primate, and human monoclonal antibodies show essentially the same result that all flaviviruses studied to date have a range of E protein epitopes ranging in flavivirus cross-reactive (e.g., mab 4G2 or 6B6C-1), to flavivirus intermediate (e.g., mab 1B7), to serocomplex specific (e.g., DENV-1 to DENV-4; mab MDVP-55A), to flavivirus species specific (e.g., mab 3H5 that is DENV-2 specific). Strain specific epitopes are rare. • Flavivirus infection induces a range of antibodies, including those that recognize multiple flaviviruses. A second, but different, flavivirus infection potentiates induction of flavivirus cross-reactive antibodies. • Most epitopes are “conformational” or “quaternary”. Very few epitopes are linear. Very few epitopes appear to elicit high titer neutralizing antibodies. Reactivity of anti-E protein mouse monoclonal antibodies raised against YF 17D vaccine with YF and 37 other flaviviruses RH: Rabbit hyperimune sera Gould et al., 1985 Reactivity of anti-E protein mouse monoclonal antibodies raised against YF 17D vaccine with YF and 37 other flaviviruses RH: Rabbit hyperimune sera Gould et al., 1985 Reactivity of anti-E and anti-NS1 protein mouse monoclonal antibodies raised against YF 17D vaccine with different YF strains Flavivirus NS1 protein Less flavivirus cross-reactive epitopes than E protein, but some still identified.
  • Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris Spelaea)

    Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris Spelaea)

    viruses Article Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris spelaea) Ian H Mendenhall 1,* , Dolyce Low Hong Wen 1,2, Jayanthi Jayakumar 1, Vithiagaran Gunalan 3, Linfa Wang 1 , Sebastian Mauer-Stroh 3,4 , Yvonne C.F. Su 1 and Gavin J.D. Smith 1,5,6 1 Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; [email protected] (D.L.H.W.); [email protected] (J.J.); [email protected] (L.W.); [email protected] (Y.C.F.S.) [email protected] (G.J.D.S.) 2 NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore 3 Bioinformatics Institute, Agency for Science, Technology and Research, Singapore 138671, Singapore; [email protected] (V.G.); [email protected] (S.M.-S.) 4 Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore 5 SingHealth Duke-NUS Global Health Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore 168753, Singapore 6 Duke Global Health Institute, Duke University, Durham, NC 27710, USA * Correspondence: [email protected] Received: 30 January 2019; Accepted: 7 March 2019; Published: 12 March 2019 Abstract: Bats are unique mammals, exhibit distinctive life history traits and have unique immunological approaches to suppression of viral diseases upon infection. High-throughput next-generation sequencing has been used in characterizing the virome of different bat species. The cave nectar bat, Eonycteris spelaea, has a broad geographical range across Southeast Asia, India and southern China, however, little is known about their involvement in virus transmission.
  • Nascent Flavivirus RNA Colocalized in Situ with Double-Stranded RNA in Stable Replication Complexes

    Nascent Flavivirus RNA Colocalized in Situ with Double-Stranded RNA in Stable Replication Complexes

    Virology 258, 108–117 (1999) Article ID viro.1999.9683, available online at http://www.idealibrary.com on View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Nascent Flavivirus RNA Colocalized in Situ with Double-Stranded RNA in Stable Replication Complexes Edwin G. Westaway,1 Alexander A. Khromykh, and Jason M. Mackenzie Sir Albert Sakzewski Virus Research Centre, Royal Children’s Hospital, Herston, Brisbane, Queensland 4029 Australia Received November 30, 1998; returned to author for revision January 20, 1999; accepted March 2, 1999 Incorporation of bromouridine (BrU) into viral RNA in Kunjin virus-infected Vero cells treated with actinomycin D was monitored in situ by immunofluorescence using antibodies reactive with Br-RNA. The results showed unequivocally that nascent viral RNA was located focally in the same subcellular site as dsRNA, the putative template for flavivirus RNA synthesis. When cells were labeled with BrU for 15 min, the estimated cycle period for RNA synthesis, the nascent Br-RNA was not digested in permeabilized cells by RNase A under high-salt conditions, in accord with our original model of flavivirus RNA synthesis (Chu, P. W. G., and Westaway, E. G., Virology 140, 68–79, 1985). The model assumes that there is on average only one nascent strand per template, which remains bound until displaced during the next cycle of RNA synthesis. The replicase complex located by BrU incorporation in the identified foci was stable, remaining active in incorporating BrU or [32P]orthophosphate in viral RNA after complete inhibition of protein synthesis in cycloheximide-treated cells.
  • Flaviviruses Infections in Neotropical Primates Suggest Long-Term

    Flaviviruses Infections in Neotropical Primates Suggest Long-Term

    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 5 November 2020 Flaviviruses infections in neotropical primates suggest long-term circulation of Saint Louis Encephalitis and Dengue virus spillback in socioeconomic regions with high numbers of Dengue human cases in Costa Rica Andrea Chaves1,2,*, Martha Piche-Ovares3, Eugenia Corrales3, Gerardo Suzán Andrés Moreira-Soto3,5†, Gustavo A. Gutiérrez-Espeleta2† 1Escuela de Biología, Universidad de Costa, San José, 11501-2060, Costa Rica; [email protected] (A.C.), [email protected] (G.A.G.E). 2Departamento de Etología, Fauna Silvestre y Animales de Laboratorio, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Av. Universidad #3000, 04510 Mexico City, D.F., Mexico; [email protected] 3Virología-CIET (Centro de Investigación de Enfermedades Tropicales), Universidad de Costa Rica, San José, 2060-1000, Costa Rica; [email protected] (M.P.O.) [email protected] (E.C.), [email protected] (A.M.S.) 4Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, Germany. *corresponding author: [email protected]; † these authors contributed equally to this work Summary: The presence of neotropical primates (NPs) positive or with antibodies against different species of Flavivirus common in Latin America, and specifically in Costa Rica (i.e. Dengue virus) has been established. However, it is unclear if a maintenance of this and other Flavivirus in sylvatic cycles exists, as has been established for yellow fever, with the howler monkey as primary host. We determined the presence of NPs seropositive to Dengue virus (DENV), Saint Louis Encephalitis virus (SLEV), West Nile virus (WNV), and undetermined Flavivirus in the country.
  • Host-Virus Interactions in the Pacific White Shrimp, Litopenaeus Vannamei Duan Sriyotee Loy Iowa State University

    Host-Virus Interactions in the Pacific White Shrimp, Litopenaeus Vannamei Duan Sriyotee Loy Iowa State University

    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2014 Host-virus interactions in the Pacific white shrimp, Litopenaeus vannamei Duan Sriyotee Loy Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Virology Commons Recommended Citation Loy, Duan Sriyotee, "Host-virus interactions in the Pacific white shrimp, Litopenaeus vannamei" (2014). Graduate Theses and Dissertations. 13777. https://lib.dr.iastate.edu/etd/13777 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Host-virus interactions in the Pacific white shrimp, Litopenaeus vannamei by Duan Sriyotee Loy A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Veterinary Microbiology Program of Study Committee: Lyric Bartholomay, Co-Major Professor Bradley Blitvich, Co-Major Professor D.L. Hank Harris Cathy Miller Michael Kimber Iowa State University Ames, Iowa 2014 Copyright © Duan Sriyotee Loy, 2014. All rights reserved. ii TABLE OF CONTENTS CHAPTER 1: GENERAL INTRODUCTION...…………………………………………...1 Introduction…………………………………………………………………………………………1 Dissertation Organization…………………………………………………………………………3
  • T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross

    T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross

    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911099; this version posted January 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross- 2 reactivity with other flavivirus species. 3 Alba Grifonia, Hannah Voica, Sandeep Kumar Dhandaa, Conner K. Kidda, James D Brienb, Søren 4 Buusc, Anette Stryhnc, Anna P Durbind, Stephen Whiteheade, Sean A. Diehlf, Aruna D. De Silvaa,g, 5 Angel Balmasedah, Eva Harrisi, Daniela Weiskopfa and Alessandro Settea,j# 6 aDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States 7 bSaint Louis University, Saint Louis, MO, United States 8 cLaboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, 9 Copenhagen, Denmark. 10 dJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD 11 eNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 12 fUniversity of Vermont, School of Medicine, Burlington, VT 13 gDepartment of Paraclinical Sciences, General Sir John Kotelawala Defense University, 14 Ratmalana, Sri Lanka. 15 hNational Virology Laboratory, National Center for Diagnosis and Reference, Ministry of Health, 16 Managua, Nicaragua 17 iDivision of Infectious Diseases and Vaccinology, School of Public Health, University of 18 California, Berkeley, CA 94720. 19 jDepartment of Medicine, University of California San Diego, La Jolla, CA, United States 20 21 Running Head: Human T cell cross-reactivity in flavivirus species 22 #Address correspondence to Dr.
  • Risk Groups: Viruses (C) 1988, American Biological Safety Association

    Risk Groups: Viruses (C) 1988, American Biological Safety Association

    Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/
  • Subverting the Mechanisms of Cell Death: Flavivirus Manipulation of Host Cell 2 Responses to Infection

    Subverting the Mechanisms of Cell Death: Flavivirus Manipulation of Host Cell 2 Responses to Infection

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Keele Research Repository 1 Subverting the mechanisms of cell death: Flavivirus manipulation of host cell 2 responses to infection 3 Elisa Vicenzi1, Isabel Pagani1, Silvia Ghezzi1, Sarah L. Taylor2, Timothy R. Rudd 3,2, Marcelo A. Lima 4,5, 4 Mark A. Skidmore5,4 and Edwin A. Yates2,4,5 5 1Viral Pathogens and Biosafety Unit, Ospedale San Raffaele, Via Olgettina 60, Milan 20132 Italy 6 2Department of Biochemistry, IIB, University of Liverpool, Crown Street, Liverpool L69 7ZB UK 7 3NIBSC, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG UK 8 4Department of Biochemistry, Universidade Federal de São Paulo, São Paulo, 04044-020 Brazil 9 5School of Life Sciences, Keele University, Keele, Staffordshire ST5 5BG UK 10 ---------------------------------------------------------------------------------------------------------------------------------------- 11 Abbreviations: 12 BAX Bcl-2-like protein 13 BAK Bcl-2-homologous killer 14 TNF-α Tissue necrosis factor alpha 15 DENV Dengue Virus 16 JEV Japanese Encephalitis Virus 17 WNV West Nile Virus 18 ZIKV Zika Virus 19 NS Flavivirus non-structural protein 20 C Flavivirus capsid protein 21 E Flavivirus envelope protein 22 M Flavivirus small membrane protein 23 IL-1β Interleukin one beta 24 IL-10 Interleukin ten 25 CASP Caspase, cysteine-aspartic protease 26 ER Entoplasmic reticulum 27 ROS Reactive oxygen species 28 P53 Tumour protein 53 29 PI31-Akt Phosphatidylinositol 3-kinase/protein kinase B signaling
  • PI3K Signaling Pathways Modulated White Spot Syndrome Virus (WSSV) T Replication in Procambarus Clarkii

    PI3K Signaling Pathways Modulated White Spot Syndrome Virus (WSSV) T Replication in Procambarus Clarkii

    Fish and Shellfish Immunology 76 (2018) 279–286 Contents lists available at ScienceDirect Fish and Shellfish Immunology journal homepage: www.elsevier.com/locate/fsi Full length article PI3K signaling pathways modulated white spot syndrome virus (WSSV) T replication in Procambarus clarkii ∗ Huijing Zhanga,b,1, Xuemei Yaob,1, Yunfei Dinga, Zheng Xua, Rongning Liangc, Ying Zhanga, , ∗∗ Yulong Wua, Boqing Lia, Bo Guanc, a School of Basic Medical Sciences, Binzhou Medical University, Yantai, 264003, Shandong, China b State Key Laboratory of Marine Resource Utilization in South China Sea, Hainan University, Haikou, 570228, Hainan, China c Key Laboratory of Coastal Zone Environmental Processes and Ecological Remediation, Yantai Institute of Coastal Zone Research (YIC), Chinese Academy of Sciences (CAS), Yantai, 264003, Shandong, China ARTICLE INFO ABSTRACT Keywords: The PI3K/AKT signaling pathway is commonly exploited to regulate viral replication and affect the fate of PI3K infected cells. In the present study, a PI3K-specific inhibitor (LY294002) was employed to pretreat crayfish to WSSV replication evaluate the effects of PI3K/AKT signaling pathway in WSSV replication. The results showed that the WSSV copy Apoptosis numbers in crayfish pretreated with LY294002 were significantly lower than those in Tris-HCl pretreatment Bax crayfish on the sixth and tenth day after WSSV infection. In semigranular cells, the apoptosis rates were up- Bax inhibitor-1 regulated on the third day post-WSSV infection, and a significantly lower proportion of apoptosis cells were Lectin Toll observed in LY294002-pretreatment group. The expression level of Bax, Bax inhibitor-1 and lectin mRNA in Procambarus clarkii haemocytes of crayfish were increased after WSSV infection.
  • Arenaviridae Astroviridae Filoviridae Flaviviridae Hantaviridae

    Arenaviridae Astroviridae Filoviridae Flaviviridae Hantaviridae

    Hantaviridae 0.7 Filoviridae 0.6 Picornaviridae 0.3 Wenling red spikefish hantavirus Rhinovirus C Ahab virus * Possum enterovirus * Aronnax virus * * Wenling minipizza batfish hantavirus Wenling filefish filovirus Norway rat hunnivirus * Wenling yellow goosefish hantavirus Starbuck virus * * Porcine teschovirus European mole nova virus Human Marburg marburgvirus Mosavirus Asturias virus * * * Tortoise picornavirus Egyptian fruit bat Marburg marburgvirus Banded bullfrog picornavirus * Spanish mole uluguru virus Human Sudan ebolavirus * Black spectacled toad picornavirus * Kilimanjaro virus * * * Crab-eating macaque reston ebolavirus Equine rhinitis A virus Imjin virus * Foot and mouth disease virus Dode virus * Angolan free-tailed bat bombali ebolavirus * * Human cosavirus E Seoul orthohantavirus Little free-tailed bat bombali ebolavirus * African bat icavirus A Tigray hantavirus Human Zaire ebolavirus * Saffold virus * Human choclo virus *Little collared fruit bat ebolavirus Peleg virus * Eastern red scorpionfish picornavirus * Reed vole hantavirus Human bundibugyo ebolavirus * * Isla vista hantavirus * Seal picornavirus Human Tai forest ebolavirus Chicken orivirus Paramyxoviridae 0.4 * Duck picornavirus Hepadnaviridae 0.4 Bildad virus Ned virus Tiger rockfish hepatitis B virus Western African lungfish picornavirus * Pacific spadenose shark paramyxovirus * European eel hepatitis B virus Bluegill picornavirus Nemo virus * Carp picornavirus * African cichlid hepatitis B virus Triplecross lizardfish paramyxovirus * * Fathead minnow picornavirus
  • Information Encoded by the Flavivirus Genomes Beyond the Nucleotide Sequence

    Information Encoded by the Flavivirus Genomes Beyond the Nucleotide Sequence

    International Journal of Molecular Sciences Review Information Encoded by the Flavivirus Genomes beyond the Nucleotide Sequence Sara Ramos-Lorente, Cristina Romero-López * and Alfredo Berzal-Herranz * Instituto de Parasitología y Biomedicina López-Neyra (IPBLN-CSIC), Av. Conocimiento 17, Armilla, 18016 Granada, Spain; [email protected] * Correspondence: [email protected] (C.R.-L.); [email protected] (A.B.-H.); Tel.: +34-958-18-16-48 (A.B.-H.) Abstract: The genus Flavivirus comprises numerous, small, single positive-stranded RNA viruses, many of which are important human pathogens. To store all the information required for their suc- cessful propagation, flaviviruses use discrete structural genomic RNA elements to code for functional information by the establishment of dynamic networks of long-range RNA–RNA interactions that promote specific folding. These structural elements behave as true cis-acting, non-coding RNAs (ncRNAs) and have essential regulatory roles in the viral cycle. These include the control of the formation of subgenomic RNAs, known as sfRNAs, via the prevention of the complete degradation of the RNA genome. These sfRNAs are important in ensuring viral fitness. This work summarizes our current knowledge of the functions performed by the genome conformations and the role of RNA–RNA interactions in these functions. It also reviews the role of RNA structure in the production of sfRNAs across the genus Flavivirus, and their existence in related viruses. Keywords: Flavivirus; RNA genomes; interactome; structure/function of RNA domains; long-distant Citation: Ramos-Lorente, S.; RNA–RNA interactions; sfRNAs Romero-López, C.; Berzal-Herranz, A. Information Encoded by the Flavivirus Genomes beyond the Nucleotide Sequence.